Skip to Content

APO 040 (Etodolac 300 mg)

Pill imprint APO 040 has been identified as Etodolac 300 mg.

Etodolac is used in the treatment of pain; osteoarthritis; rheumatoid arthritis; juvenile rheumatoid arthritis and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy. Etodolac 300 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Etodolac 300 mg APO 040
Etodolac 300 mg APO 040
APO 040
300 mg
Gray & White
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Apotex Corp.
National Drug Code (NDC):
Inactive Ingredients:
ferrosoferric oxide
silicon dioxide
croscarmellose sodium
lactose monohydrate
sodium lauryl sulfate
stearic acid
magnesium silicate
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
23490-5556 Palmetto State Pharmaceuticals Inc (repackager)
33358-0137 CorePharma, LLC (repackager)
66336-0376 Dispensing Solutions Inc. (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.